Chembio Diagnostics to Report Second Quarter 2021 Financial Results on August 5, 2021
HAUPPAUGE, N.Y., July 22, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the second quarter of 2021 after the close of trading on Thursday, August 5, 2021.
- HAUPPAUGE, N.Y., July 22, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the second quarter of 2021 after the close of trading on Thursday, August 5, 2021.
- The companys management team will host a corresponding conference call beginning at 4:30 p.m. Eastern Time on August 5, 2021.
- Chembio is a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases, including COVID-19, sexually transmitted disease, and fever and tropical disease.
- Coupled with Chembios extensive scientific expertise, its novel DPP technology offers broad market applications beyond infectious disease.